RxDoctor Payments Data

Juan Munoz, MD

Gastroenterology · Jacksonville, FLNPI 1417924788

Payments from drug & device makers

What this record shows

Intuitive Surgical accounts for 60.5% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $1,105, more than ten times the $59 reported in 2021. That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.

$1,702in general payments, 2019–2025

Across 29 payments — averaging $58.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • AbbVie$328
  • Atricure, Inc.$131
  • Pfizer$66
  • Phathom Pharmaceuticals, Inc.$64
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$36
  • plus $49 from 3 others
$24,663in research payments, 2019–2025

Across 14 payments — averaging $1761.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$14K
  • Vanda Pharmaceuticals Inc.$11K

What the payments were for

  • Food & beverage$70241%
  • Education$1,00059%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,702 in reported general payments places this provider in the 35th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida →

Medicare billing

Part B allowed, 2024
$356,974
Medicare patients
404
Services billed
14,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase65$106,900
LinzessLinaclotide16$19,276
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates96$5,820
Famotidine190$2,634
Pantoprazole Sodium163$1,364
Omeprazole75$1,204
Lubiprostone13$767
Sucralfate27$662
Ondansetron Hcl13$453
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl25$420
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$197

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$328$126,17681 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,388 gastroenterology providers in Florida.

Other gastroenterology in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →